IBDEI062 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2591,1,2,0)
 ;;=2^DIABETES TYPE II w/ SPEC MANIF
 ;;^UTILITY(U,$J,358.3,2591,2)
 ;;=^331811
 ;;^UTILITY(U,$J,358.3,2592,0)
 ;;=250.81^^22^205^7
 ;;^UTILITY(U,$J,358.3,2592,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2592,1,1,0)
 ;;=1^250.81
 ;;^UTILITY(U,$J,358.3,2592,1,2,0)
 ;;=2^DIABETES TYPE I w/ SPEC MANIF
 ;;^UTILITY(U,$J,358.3,2592,2)
 ;;=^331812
 ;;^UTILITY(U,$J,358.3,2593,0)
 ;;=368.8^^22^205^18
 ;;^UTILITY(U,$J,358.3,2593,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2593,1,1,0)
 ;;=1^368.8
 ;;^UTILITY(U,$J,358.3,2593,1,2,0)
 ;;=2^VISUAL DISTURBANCES NEC
 ;;^UTILITY(U,$J,358.3,2593,2)
 ;;=^88172
 ;;^UTILITY(U,$J,358.3,2594,0)
 ;;=303.90^^22^205^6
 ;;^UTILITY(U,$J,358.3,2594,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2594,1,1,0)
 ;;=1^303.90
 ;;^UTILITY(U,$J,358.3,2594,1,2,0)
 ;;=2^ALCOHOL DEP NEC/NOS,UNSPEC
 ;;^UTILITY(U,$J,358.3,2594,2)
 ;;=^4648
 ;;^UTILITY(U,$J,358.3,2595,0)
 ;;=303.91^^22^205^3
 ;;^UTILITY(U,$J,358.3,2595,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2595,1,1,0)
 ;;=1^303.91
 ;;^UTILITY(U,$J,358.3,2595,1,2,0)
 ;;=2^ALCOHOL DEP NEC/NOS,CONTINUOUS
 ;;^UTILITY(U,$J,358.3,2595,2)
 ;;=^268188
 ;;^UTILITY(U,$J,358.3,2596,0)
 ;;=303.92^^22^205^4
 ;;^UTILITY(U,$J,358.3,2596,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2596,1,1,0)
 ;;=1^303.92
 ;;^UTILITY(U,$J,358.3,2596,1,2,0)
 ;;=2^ALCOHOL DEP NEC/NOS,EPISODIC
 ;;^UTILITY(U,$J,358.3,2596,2)
 ;;=^268189
 ;;^UTILITY(U,$J,358.3,2597,0)
 ;;=303.93^^22^205^5
 ;;^UTILITY(U,$J,358.3,2597,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2597,1,1,0)
 ;;=1^303.93
 ;;^UTILITY(U,$J,358.3,2597,1,2,0)
 ;;=2^ALCOHOL DEP NEC/NOS,IN REMISSION
 ;;^UTILITY(U,$J,358.3,2597,2)
 ;;=^268190
 ;;^UTILITY(U,$J,358.3,2598,0)
 ;;=V11.3^^22^205^10
 ;;^UTILITY(U,$J,358.3,2598,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2598,1,1,0)
 ;;=1^V11.3
 ;;^UTILITY(U,$J,358.3,2598,1,2,0)
 ;;=2^HX OF ALCOHOLISM
 ;;^UTILITY(U,$J,358.3,2598,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,2599,0)
 ;;=V68.1^^22^206^13
 ;;^UTILITY(U,$J,358.3,2599,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2599,1,1,0)
 ;;=1^V68.1
 ;;^UTILITY(U,$J,358.3,2599,1,2,0)
 ;;=2^MEDICATION RENEWAL
 ;;^UTILITY(U,$J,358.3,2599,2)
 ;;=^295585
 ;;^UTILITY(U,$J,358.3,2600,0)
 ;;=V65.49^^22^206^12
 ;;^UTILITY(U,$J,358.3,2600,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2600,1,1,0)
 ;;=1^V65.49
 ;;^UTILITY(U,$J,358.3,2600,1,2,0)
 ;;=2^MEDICATION COUNSELING
 ;;^UTILITY(U,$J,358.3,2600,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,2601,0)
 ;;=250.92^^22^206^3
 ;;^UTILITY(U,$J,358.3,2601,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2601,1,1,0)
 ;;=1^250.92
 ;;^UTILITY(U,$J,358.3,2601,1,2,0)
 ;;=2^DIABETES W/UNSPEC COMP TYPE II
 ;;^UTILITY(U,$J,358.3,2601,2)
 ;;=^295722
 ;;^UTILITY(U,$J,358.3,2602,0)
 ;;=250.00^^22^206^2
 ;;^UTILITY(U,$J,358.3,2602,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2602,1,1,0)
 ;;=1^250.00
 ;;^UTILITY(U,$J,358.3,2602,1,2,0)
 ;;=2^DIABETES II
 ;;^UTILITY(U,$J,358.3,2602,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,2603,0)
 ;;=V67.51^^22^206^5
 ;;^UTILITY(U,$J,358.3,2603,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2603,1,1,0)
 ;;=1^V67.51
 ;;^UTILITY(U,$J,358.3,2603,1,2,0)
 ;;=2^HI-RISK RX F/U EXAM,NEC
 ;;^UTILITY(U,$J,358.3,2603,2)
 ;;=^295577
 ;;^UTILITY(U,$J,358.3,2604,0)
 ;;=V14.9^^22^206^7
 ;;^UTILITY(U,$J,358.3,2604,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2604,1,1,0)
 ;;=1^V14.9
 ;;^UTILITY(U,$J,358.3,2604,1,2,0)
 ;;=2^HX-DRUG ALLERGY NOS
 ;;^UTILITY(U,$J,358.3,2604,2)
 ;;=^295282
 ;;^UTILITY(U,$J,358.3,2605,0)
 ;;=V15.81^^22^206^6
 ;;^UTILITY(U,$J,358.3,2605,1,0)
 ;;=^358.31IA^2^2
